Published in
American Medical Association, JAMA Internal Medicine, 1(183), p. 82, 2023
DOI: 10.1001/jamainternmed.2022.5419
Links
Tools
Frequency of Approval and Marketing of Biosimilars With a Skinny Label and Associated Medicare Savings
Journal article published in 2022 by
Alexander C. Egilman,
Victor L. Van de Wiele,
Benjamin N. Rome,
Jonathan J. Darrow,
S. Sean Tu,
Aaron S. Kesselheim,
Ameet Sarpatwari
Distributing this paper is prohibited by the publisher
Full text: Unavailable
Preprint: archiving forbidden
Postprint:
archiving forbidden
Published version:
archiving forbidden
Data provided by 
Abstract
This cohort study assesses the frequency of approval and marketing of skinny-label biosimilars and their savings to Medicare.